Impact of a Clinical Decision Support System on the Efficiency and Effectiveness of Performing Medication Reviews in Community Pharmacies: A Randomized Controlled Trial.

IF 2.4 4区医学 Q2 HEALTH CARE SCIENCES & SERVICES Healthcare Pub Date : 2024-12-09 DOI:10.3390/healthcare12232491

Armin Dabidian, Florian Kinny, Melina Steichert, Sabina Schlottau, Anke Bartel, Holger Schwender, Stephanie Laeer

{"title":"Impact of a Clinical Decision Support System on the Efficiency and Effectiveness of Performing Medication Reviews in Community Pharmacies: A Randomized Controlled Trial.","authors":"Armin Dabidian, Florian Kinny, Melina Steichert, Sabina Schlottau, Anke Bartel, Holger Schwender, Stephanie Laeer","doi":"10.3390/healthcare12232491","DOIUrl":null,"url":null,"abstract":"Background: Clinical decision support systems (CDSSs) already support community pharmacists in conducting medication reviews (MRs) by identifying important information on interactions and suggesting clinical solutions. However, their impact in terms of quality and time savings is widely unexplored. The aim of our study was to investigate whether MRs are performed faster and better with or without using a CDSS.Methods: In a randomized controlled study with a cross-over design, 71 pharmacists performed a total of four MRs, two with and two without the use of a CDSS. The primary endpoint was defined as the time required for the MRs. The secondary endpoints were the number of predefined relevant drug-related problems (DRPs) detected and pharmacist satisfaction.Results: Without the use of a CDSS, pharmacists needed between 25.7% and 30.7% more time to perform a MR than with a CDSS. In addition, significantly more relevant DRPs were detected in the MRs with CDSS than without CDSS (70% vs. 50%; p = 0.0037). Furthermore, participants stated that they felt more confident using a CDSS for MRs than without.Conclusions: Our results demonstrate that MRs can be performed both faster and better when using a CDSS than without. Consequently, community pharmacists benefit from the use of CDSSs for MRs, as do patients in terms of their drug therapy safety.","PeriodicalId":12977,"journal":{"name":"Healthcare","volume":"12 23","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Healthcare","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/healthcare12232491","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Clinical decision support systems (CDSSs) already support community pharmacists in conducting medication reviews (MRs) by identifying important information on interactions and suggesting clinical solutions. However, their impact in terms of quality and time savings is widely unexplored. The aim of our study was to investigate whether MRs are performed faster and better with or without using a CDSS.

Methods: In a randomized controlled study with a cross-over design, 71 pharmacists performed a total of four MRs, two with and two without the use of a CDSS. The primary endpoint was defined as the time required for the MRs. The secondary endpoints were the number of predefined relevant drug-related problems (DRPs) detected and pharmacist satisfaction.

Results: Without the use of a CDSS, pharmacists needed between 25.7% and 30.7% more time to perform a MR than with a CDSS. In addition, significantly more relevant DRPs were detected in the MRs with CDSS than without CDSS (70% vs. 50%; p = 0.0037). Furthermore, participants stated that they felt more confident using a CDSS for MRs than without.

Conclusions: Our results demonstrate that MRs can be performed both faster and better when using a CDSS than without. Consequently, community pharmacists benefit from the use of CDSSs for MRs, as do patients in terms of their drug therapy safety.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

背景：临床决策支持系统（CDSS）通过识别相互作用的重要信息并提出临床解决方案，已经为社区药剂师进行药物回顾（MR）提供了支持。然而，这些系统在提高质量和节省时间方面的影响尚未得到广泛探讨。我们的研究旨在调查使用或不使用 CDSS 是否能更快更好地进行 MR：在一项采用交叉设计的随机对照研究中，71 名药剂师共进行了四次磁共振检查，两次使用了 CDSS，两次未使用。主要终点定义为 MR 所需的时间。次要终点是检测到的预定义相关药物问题 (DRP) 的数量和药剂师的满意度：结果：在未使用 CDSS 的情况下，药剂师执行 MR 所需的时间比使用 CDSS 时多 25.7% 至 30.7%。此外，在使用 CDSS 的 MR 中检测到的相关 DRP 明显多于未使用 CDSS 的 MR（70% 对 50%；p = 0.0037）。此外，参与者还表示，与未使用 CDSS 相比，他们对使用 CDSS 检测 MR 更有信心：我们的研究结果表明，使用 CDSS 比不使用 CDSS 能更快更好地完成 MR。因此，社区药剂师可以从使用 CDSS 进行磁共振检查中获益，患者也可以从药物治疗安全性方面获益。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Healthcare Medicine-Health Policy

CiteScore

3.50

自引率

7.10%

发文量

审稿时长

47 days

期刊介绍： Healthcare (ISSN 2227-9032) is an international, peer-reviewed, open access journal (free for readers), which publishes original theoretical and empirical work in the interdisciplinary area of all aspects of medicine and health care research. Healthcare publishes Original Research Articles, Reviews, Case Reports, Research Notes and Short Communications. We encourage researchers to publish their experimental and theoretical results in as much detail as possible. For theoretical papers, full details of proofs must be provided so that the results can be checked; for experimental papers, full experimental details must be provided so that the results can be reproduced. Additionally, electronic files or software regarding the full details of the calculations, experimental procedure, etc., can be deposited along with the publication as “Supplementary Material”.